Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Manitex International | MNTX | Nov 25, 2024 | 5.73 | -0.17 |
Manitowoc | MTW | Nov 25, 2024 | 10.95 | +1.30 |
Mannatech | MTEX | Nov 25, 2024 | 7.88 | -6.19 |
MannKind | MNKD | Nov 25, 2024 | 6.72 | -1.75 |
ManpowerGroup | MAN | Nov 25, 2024 | 64.77 | +3.67 |
Manulife Financial | MFC | Nov 25, 2024 | 31.96 | -1.57 |
Maplebear | CART | Nov 25, 2024 | 43.61 | +0.90 |
Marathon Digital | MARA | Nov 25, 2024 | 26.42 | +1.50 |
Marathon Oil | MRO | Nov 25, 2024 | 28.55 | 0.00 |
Marathon Petroleum | MPC | Nov 25, 2024 | 156.50 | -1.25 |
Maravai LifeSciences A | MRVI | Nov 25, 2024 | 5.29 | +1.34 |
Marblegate Acquisition A | GATE | Nov 25, 2024 | 11.13 | 0.00 |
Marchex B | MCHX | Nov 25, 2024 | 1.74 | +5.45 |
Marcus | MCS | Nov 25, 2024 | 22.10 | +0.32 |
Marcus & Millichap | MMI | Nov 25, 2024 | 42.22 | +2.48 |
Marex Group | MRX | Nov 25, 2024 | 28.95 | -0.79 |
Marin Software | MRIN | Nov 25, 2024 | 2.12 | +0.47 |
Marine Petroleum Trust U | MARPS | Nov 25, 2024 | 4.05 | -0.12 |
Marine Products | MPX | Nov 25, 2024 | 10.21 | +2.30 |
MarineMax | HZO | Nov 25, 2024 | 33.39 | +9.26 |
Marinus Pharmaceuticals | MRNS | Nov 25, 2024 | 0.32 | -0.37 |
Maris-Tech | MTEK | Nov 25, 2024 | 1.80 | +5.27 |
Markel | MKL | Nov 25, 2024 | 1 761.62 | +0.66 |
Marker Therapeutics | MRKR | Nov 25, 2024 | 3.33 | +7.42 |
Market Vectors Bdc Income ETF | BIZD | Nov 25, 2024 | 16.74 | +0.42 |
Market Vectors Investment Grade | FLTR | Nov 25, 2024 | 25.49 | -0.04 |
Market Vectors Israel ETF | ISRA | Nov 25, 2024 | 43.06 | +1.91 |
Market Vectors Preferred Securi | PFXF | Nov 25, 2024 | 18.09 | +0.39 |
MarketAxess | MKTX | Nov 25, 2024 | 263.80 | +1.33 |
MarketWise A | MKTW | Nov 25, 2024 | 0.52 | -2.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.